Health care
The GLP-1 Shortage Is Over. Mass-Market Compounding Should Be, Too
The U.S. Food and Drug Administration’s effort to rein in mass-market copies of blockbuster GLP-1 drugs just survived a major legal challenge. Last month, the U.S. Court of Appeals for the Fifth Circuit upheld the agency’s determination that the…
The first mRNA flu vaccine may be just the beginning
Flu season is coming. And for the first time, Americans will have an mRNA vaccine to help fight it.…
Mark Cuban: Insurance Can Make Prescription Drugs Cost…
Billionaire entrepreneur Mark Cuban has picked another fight with pharmacy benefit managers, the…
Millions of women missing breast cancer screenings due…
More than 8 million American women between 45 and 64 are overdue for breast-cancer screening. That’s…
Former Minnesota Rep. Doug Reuter learned the limits of…
Doug Reuter grew up in the Twin Cities, lived in Eden Prairie, then settled his family in Owatonna.…
Use Trade Policy to Push Wealthy Nations to Pay More for Meds
President Trump just announced another round of agreements with pharmaceutical companies under his “most-favored-nation” drug pricing initiative. The nine new deals bring the total number of participating manufacturers to 26, covering nearly 90% of…
A new name for a better way to buy health insurance
Federal officials just gave one of the most promising innovations in health insurance a badly needed…
Minnesota’s Trans Laws and the WPATH Collapse
The Minnesota Legislature passed trans-refuge and coverage laws that pressed doctors, hospitals, and…
GOP Shouldn’t Run Away from Healthcare Reform
The Midterms Loom, Republicans Would Be Wise to Run on Healthcare Reform Ever since the…
Association Health Plans Could Give Small Businesses A…
Small businesses have struggled with the rising cost of health insurance for years. The Trump…
TRENDING
